Full-Time

Manager – Systems Engineering

Posted on 9/28/2025

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Sunnyvale, CA, USA

In Person

Category
Biology & Biotech (2)
,
Required Skills
OrCAD
Oscilloscope
Requirements
  • Bachelor's or Master's degree in Electrical Engineering, Biomedical Engineering, or a closely related field.
  • Minimum of 7+ years of progressive experience in electrical engineering within the medical device industry, with at least 3 years in a senior or lead systems engineering role.
  • Demonstrated expert-level knowledge of IEC 60601-1 (including Amendment 2) and its relevant collateral standards (e.g., IEC 60601-1-2, -1-6, -1-8, -1-11).
  • Proven experience in applying ISO 14971 (Risk Management for Medical Devices) principles to hardware design and safety.
  • Strong proficiency in analog and digital circuit design, power supply design (AC-DC, DC-DC), sensor integration, and signal conditioning for patient-facing applications.
  • Hands-on experience with schematic capture and PCB layout tools (e.g., Altium Designer, OrCAD, Cadence).
  • Expertise with electrical test and measurement equipment (oscilloscopes, multimeters, power analyzers, hipot testers, leakage current testers, spectrum analyzers, etc.).
  • Excellent understanding of electromagnetic compatibility (EMC) design principles and experience with EMC testing for medical devices.
  • Familiarity with medical device quality management systems (e.g., ISO 13485, FDA QSR).
  • Exceptional written and verbal communication skills, with a proven ability to distill complex technical information into clear, actionable insights for non-technical audiences. This includes strong presentation skills.
  • Superior problem-solving, analytical, and critical thinking abilities.
Responsibilities
  • Lead the definition and decomposition of detailed system requirements, ensuring traceability to user needs, product specifications, and global regulatory standards.
  • Architect and optimize electrical systems, including power distribution, signal integrity, sensor interfaces, control systems, and user interface elements, in close collaboration with mechanical, software, and clinical engineering teams.
  • Drive robust design decisions that balance performance, reliability, cost, manufacturability, and long-term serviceability.
  • Articulate highly technical electrical and safety concepts clearly and concisely to non-technical audiences, including marketing, sales, clinical specialists, regulatory affairs, and senior management.
  • Develop simplified explanations, diagrams, and presentations to convey complex electrical design rationale, safety measures, and compliance strategies.
  • Represent the engineering team in cross-functional meetings, regulatory audits, and discussions with external partners, ensuring transparent and understandable communication.
  • Prepare clear and compelling technical reports, white papers, and documentation that can be understood by various stakeholders.
  • Act as the company's leading subject matter expert (SME) on IEC 60601-1 and its associated collateral standards.
  • Proactively embed IEC 60601-1 compliance into electrical designs from the earliest concept stages through to final product verification.
  • Define, oversee, and interpret results from electrical safety testing protocols (e.g., leakage current, dielectric strength, protective earthing, creepage and clearance distances, insulation coordination).
  • Collaborate with external test houses and Notified Bodies to facilitate smooth safety and EMC testing for global product certifications.
  • Develop and maintain comprehensive documentation, including technical reports, compliance matrices, and risk management files (per ISO 14971) related to electrical safety.
  • Act as a key technical leader, fostering strong collaboration across all engineering disciplines and functional groups (Quality, Regulatory, Manufacturing, Clinical).
  • Mentor and provide technical guidance to junior electrical and systems engineers, promoting best practices in design, safety, and documentation.
  • Maintain up-to-date knowledge of evolving medical device regulations, industry standards (especially for electrical safety and EMC), and emerging systems engineering technologies.
  • Proactively identify and champion opportunities for process improvement within the systems and hardware engineering functions.
Desired Qualifications
  • Experience with high-voltage and high-power electrical systems in medical devices.
  • Understanding of embedded systems and firmware development lifecycle (e.g., IEC 62304).
  • Experience in conducting or supporting root cause analysis (RCA) investigations related to electrical failures.
  • Prior involvement in successful regulatory submissions (e.g., 510(k), CE Mark) and direct interaction with regulatory agencies.

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Simplify Jobs

Simplify's Take

What believers are saying

  • Bariatric surgery market expansion as da Vinci outperforms GLP-1 drugs for sustained weight loss.
  • Ion bronchoscopy system procedures grew 39% YoY with 1,041 installed units capturing lung cancer detection.
  • Less than 5% of eligible surgeries globally performed robotically indicates substantial international adoption runway.

What critics are saying

  • FDA Class II recalls of instruments with fraying cables disrupt 86% of Q1 recurring revenue.
  • FDA safety communication on curved tip staplers halts hospital use, eroding surgeon confidence in reliability.
  • EU MDR recertification deadline December 2028 halts 25% European sales during redesign and testing.

What makes Intuitive Surgical unique

  • 70-80% market share in soft-tissue robotics with 11,395 installed da Vinci systems globally.
  • 85% recurring revenue from instruments, accessories, and service contracts provides predictable cash flow.
  • da Vinci 5 platform expands into cardiac surgery and complex procedures previously requiring open surgery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Apr 7th, 2026
Intuitive Surgical emerges as dark horse in anti-obesity market as surgery outperforms GLP-1 drugs

Intuitive Surgical could emerge as a dark horse in the anti-obesity market as bariatric surgery proves more effective than GLP-1 drugs for long-term weight loss. A recent study of over 50,000 patients found surgery patients lost an average of 58 pounds after two years, compared to just 12 pounds for those using GLP-1 medications. The study also showed surgery delivers more sustainable results. Gastric bypass patients maintain around 52% of their excess weight loss after 10 years, whilst GLP-1 users often regain all lost weight after stopping treatment. Intuitive's da Vinci surgical system offers minimally invasive bariatric surgery options. The company generated $10.1 billion in revenue last year, up from $8.4 billion, with profit margins around 28%. Despite shares falling over 20% this year, the company's position in surgical innovation makes it a compelling long-term investment.

Yahoo Finance
Mar 29th, 2026
Intuitive Surgical shares drop 19% YTD, but analysts see 15% upside potential

Intuitive Surgical has experienced recent share price weakness, declining 3% in one day with negative returns over the past week, month and three months. The stock currently trades at $452.66, down 10.1% over one month and 19.45% year-to-date, though three-year total shareholder returns remain strong at 77.19%. The medical technology company reports annual revenue of $10.1 billion and net income of $2.9 billion, maintaining a dominant position in minimally invasive surgical technology. According to one valuation analysis, Intuitive Surgical's fair value sits at $532.46, suggesting the stock is undervalued by approximately 15% at current levels. The analysis projects 12% annual revenue growth over the next five years, supported by recurring revenues from spare parts and software licences, with profit margins expected to reach 30% from the current 28.6%.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical shares up 23% after Jim Cramer's buy recommendation

Intuitive Surgical shares rose 23% following Jim Cramer's recommendation on CNBC's Squawk on the Street in June 2025, where he urged investors to "just go buy ISRG". The medical robotics company experienced a 27% surge in October after reporting third-quarter earnings that beat analyst estimates. Revenue reached $2.51 billion against expectations of $2.40 billion, whilst adjusted earnings per share hit $2.40 versus the predicted $1.98. However, the stock declined 2.7% in January 2026 after Intuitive Surgical released preliminary fourth-quarter results, citing concerns that Medicaid funding cuts and competing products could slow growth of its robotic surgical systems. Despite the recent setback, shares remain up significantly since Cramer's initial endorsement, though they're down 7.8% over the past year.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical faces tariff headwinds and rising competition despite 19% revenue growth to $2.87B

Intuitive Surgical faces headwinds from tariffs and increased competition in the robotic-assisted surgery market, yet its fundamentals remain strong. The medical device company reported fourth-quarter revenue growth of 19% to $2.87 billion, whilst adjusted earnings per share rose 14.5% to $2.53. Procedures using its da Vinci surgical system increased 17%, with the installed base growing 12% to 11,106 units. However, the stock trades at 47.6 times forward earnings, compared to the healthcare sector average of 17.1. New competition is emerging, with Medtronic's Hugo system recently cleared and Johnson & Johnson expected to launch its own device soon. Despite these challenges, Intuitive Surgical maintains advantages through switching costs and extensive real-world data, whilst the underpenetrated robotic-assisted surgery market offers long-term growth potential.

Yahoo Finance
Mar 24th, 2026
ISRG maintains 37% operating margins in Q4 despite 95 bps tariff drag

Intuitive Surgical maintained a 37% operating margin in Q4 despite tariffs creating a 95 basis point drag, alongside higher facility costs and unfavourable product mix from newer platforms like da Vinci 5 and Ion. The company offset these pressures through product cost reductions, component savings and manufacturing efficiencies. Procedure growth of 18% in Q4 and recurring revenue now comprising 81% of total revenues provided operating leverage. Management's 2026 gross margin guidance of 67-68% suggests continued stability, even as tariff headwinds are expected to increase to roughly 1.2% of revenues. Meanwhile, Boston Scientific expanded adjusted operating margins by 100 basis points to 28% in 2025, though tariffs will offset favourable product mix in 2026. The company expects 50-75 basis points operating margin expansion in 2026 through scale efficiencies and supply-chain optimisation.

INACTIVE